[144] KLX Energy Services Holdings, Inc. SEC Filing
Rhea-AI Filing Summary
KLX Energy Services Holdings, Inc. submitted a Form 144 notifying the market of a proposed sale of 8,250 shares of common stock, with an aggregate market value of $15,510, to be offered on 08/18/2025 on Nasdaq through Merrill Lynch Pierce Fenner & Smith, Inc. The filing identifies total shares outstanding of 17,840,457, and records that the securities were acquired as stock bonuses on 02/01/2024 (1,041 shares) and 02/01/2025 (7,209 shares).
The notice lists no sales by the reporting person in the past three months and includes the standard signer representation that no material nonpublic information is known. The filing appears to be a routine Rule 144 notice documenting the proposed disposition and the acquisition history of the shares to be sold.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Rule 144 notice for a small proposed sale; limited investor impact based on disclosed size and timing.
The Form 144 indicates a planned sale of 8,250 common shares valued at $15,510 on 08/18/2025 via Merrill Lynch. The securities were acquired as stock bonuses on 02/01/2024 and 02/01/2025. The filing also reports no securities sold in the past three months by the reporting person, suggesting this is a singular, scheduled disposition under Rule 144 rather than an active selling program. From a market-microstructure perspective the size disclosed is small relative to the 17,840,457 shares outstanding and therefore unlikely to materially affect liquidity or valuation on its own.
TL;DR: Disclosure demonstrates procedural compliance with Rule 144 and includes the required signer representation about material information.
The notice provides broker details and acquisition dates, and includes the standard attestation that the signer does not possess undisclosed material adverse information. The filing being marked LIVE and listing the broker (Merrill Lynch Pierce Fenner & Smith, Inc.) indicates the filer is following prescribed disclosure steps for the proposed sale. There are no indications in the form of unusual concentrations, repeated recent sales, or other governance red flags in the disclosed content.